| A |
|
Acanthamoeba castellanii is a model for eukaryote-prokaryote interaction and a human pathogen
|
| Abd H., Saeed A., Advinsson B., Sandström G. |
| |
|
Acinetobacter infections: a growing threat for critically ill patients
|
| Falagas M.E., Karveli E., Siempos I., Vardakas K. |
| |
|
Arcanobacterium haemolyticum as a cause of pharyngotonsillitis in Santander (Spain): incidence, clinical features and antimicrobial susceptibility
|
| Garcia C., Campo-Esquisabel A.B., Unda F., Ruiz de Alegría C., Agüero J. |
| |
|
Aspergillus fumigatus biofilms are refractory to antifungal challenge
|
| Mowat E., Butcher J., Williams C., Ramage G. |
| |
|
Aspergillus endophthalmitis in an immunocompetent woman: intra-ocular penetration of oral voriconazole
|
| Logan S., Graham E., Rajan M., Johnson E., Klein J. |
| |
|
Aspergillus keratomycosis at an eye hospital in south India: a retrospective study
|
| Kredics L., Manikandan P., Kocsubé S., Dóczi I., Narendran V., Varga J., Antal Z., Vágvölgyi C., Revathi R., Nagy E. |
| |
|
A CA-MRSA strain with decreased vancomycin susceptibility as a cause of serious invasive infection in an immunocompetent adolescent
|
| Tronci M., Parisi G., Pantosti A., Monaco M., Valentini P. |
| |
|
A case of Ralstonia paucula septicaemia in an intensive care patient following blood transfusion via a level-1 fast flow fluid warmer, successfully treated with meropenem
|
| Clark B.M., Townsend R., Norman P. |
| |
|
A child with endocarditis due to Enterobacter cloacae responded to long-term antibiotic treatment without cardiac surgery
|
| Klont R.R., Noordzij J.G., Bot P., Schülin-Casonato T., Warris A. |
| |
|
A comparative study for the determination of IgG avidity during a toxoplasmosis infection in pregnancy
|
| Krispenz U., Wassenberg D., Becker W., Pfrepper K. |
| |
|
A comparative study of the new Access® HBs Ag assay and the HBs Ag confirmatory assay from Beckman Coulter
|
| Duburcq X., Pouzet A., Marant L., Clément A., Duhamel D., Leirens Y., Margotteau F., Falcou-Briatte R., Bouniort F., Taskar S., Flecheux O. |
| |
|
A comparative study of treatment outcome in cryptococcal meningitis in HIV-infected patients during period before versus after implementation of treatment guidelines for management of increased intracranial pressure
|
| Putcharoen O., Kulwichit W., Tantawichien T., Hanvanich M., Suankratay C. |
| |
|
A comparative study on the antibiotic consumption of two Hungarian county hospitals
|
| Almási I., Ternák G., Rozgonyi F. |
| |
|
A comparative study on the frequency of genes encoding cytotoxins in Austrian, Hungarian and Macedonian methicillin-resistant and sensitive Staphylococcus aureus strains
|
| Kocsis E., Pesti N., Kristóf K., Nagy K., Cekovska Z., Lagler H., Stich K., Graninger W., Rozgonyi F. |
| |
|
A comparison of antimicrobial susceptibility in non-clinical and clinical isolates of Escherichia coli
|
| Sjölund M., Bonnedahl J., Bengtsson S., Kahlmeter G. |
| |
|
A comparison of the CLSI (formerly NCCLS), EUCAST and various EU country standard methods for the susceptibility testing of retapamulin, a novel pleuromutilin
|
| Williams L., Colclough A., Felmingham D. |
| |
|
A cost-effective study of VRE surveillance in a Greek university hospital
|
| Charalambakis N., Pantelaki M., Chatzigeorgiou K., Kapi M., Siafakas N., Galani L., Zerva L. |
| |
|
A decade of levofloxacin: summary of the cumulative clinical trial safety database
|
| Peterson J., Fisher A., Khashab M., Kahn J. |
| |
|
A four-year epidemiological study of aetiological agents of yeast infections and antifungal susceptibility profiles in the centre of Portugal
|
| Paulo C., Marques J., Mourão C., Meliço-Silvestre A., Florindo A., Gonçalves T. |
| |
|
A low nurse-to-patient ratio is an independent risk factor for late-onset VAP
|
| Uçkay I., Hugonnet S., Sax H., Pittet D. |
| |
|
A meta-analysis of risk factors for mortality in patients with emphysematous pyelonephritis
|
| Falagas M.E., Alexiou V.G., Giannopoulou K.P., Siempos I.I. |
| |
|
A multicentre, double-blind, randomised clinical trial of parenteral cefepime in the treatment of acute bacterial infections
|
| Lu X.J. |
| |
|
A multiplex microsphere-based assay for the simultaneous detection of C. parvum, E. histolytica and G. lamblia antigen in human faecal sample
|
| Groen J., Huwe A., Su X., Cox S., Truong H., Nguyen P., Laderman E. |
| |
|
A new automated magnetic bead based nucleic acid sample preparation directly from nasal swabs for MRSA diagnostics
|
| Kolpus T.E., Høidal Berthelsen H.K., Lorentzen M., Refseth U.H. |
| |
|
A new chromogenic agar medium, chromID VRE®, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis
|
| Ledeboer N., Tibbetts R., Dunne M. |
| |
|
A new fast automated magnetic bead based nucleic acid sample preparation for STI diagnostics combined with BD ProbeTecTM ET
|
| Engen T., Anglès d'Auriac M., Harja S., Tauvo-Kallio M., Rantakokko-Jalava K., Refseth U. |
| |
|
A new mass-spectrometric approach to antibacterial susceptibility testing
|
| Vereshchagin V., Ilina E., Atroshkina M., Serebryakova M., Maier T., Kostrzewa M., Govorun V. |
| |
|
A new metallo-b-lactamase gene (blaIMP-22) harboured in class 1 integron from Pseudomonas fluorescens
|
| Pellegrini C., Celenza G., Mercuri P., Galleni M., Segatore B., Amicosante G., Perilli M. |
| |
|
A new protein conjugate vaccine for polymicrobial diseases: a case study (POET)
|
| Hausdorff W.P. |
| |
|
A new type of TT virus in eastern Taiwanese indigenes
|
| Liu H.-F., Hsiao K.-L., Lee H.-H., Lin C.-L., Lee Y.-J., Wang L.-Y. |
| |
|
A nosocomial outbreak due to Serratia marcescens in a West-Tallinn hospital
|
| Zolotuhhina I., Voiko R., Albri P., Adamson V., Allik K. |
| |
|
A novel antimicrobial peptide with anti-MRSA activity
|
| Aunpad R., Na-Bangchang K. |
| |
|
A novel chromogenic medium for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis detection
|
| Cuzon G., Naas T., Fortineau N., Nordmann P. |
| |
|
A novel method for the detection of extended-spectrum b-lactamases, metallo-b-lactamases and AmpC producing Gram-negative bacilli in a single test: the CICA beta-test
|
| M'Zali F., Arpin C., Dubois V., Andre C., Quentin C. |
| |
|
A novel not b-lactam inhibitor of DD-peptidase 64–575
|
| Solecka J., Rajnisz A., Laudy A., Kurzatkowski W. |
| |
|
A pharmacodynamic analysis of resistance trends in pathogens from patients with infection in intensive care units in the USA between 1993 and 2004
|
| Eagye K., Nicolau D., Heilmann K., Quinn J., Doern G., Gallagher G., Abramson M. |
| |
|
A planned dramatic drop in trimethoprim consumption in a 180,000 population did not result in a related decrease in trimethoprim resistance in Escherichia coli
|
| Andersson D.I., Sundqvist M., Sjölund M., Runehagen A., Cars H., Abelson-Storby K., Cars O., Kahlmeter G. |
| |
|
A practical approach to post-discharge surveillance of surgical site infections
|
| Knaust A., Moussa A., Eikmann T., Herr C. |
| |
|
A proposed mechanism of action of glucocorticosteroids in severe sepsis
|
| Giamarellos-Bourboulis E., Orfanos S., Pelekanou A., Kotanidou A., Tzepi I., Armaganidis A., Spyridaki E., Dimopoulou I. |
| |
|
A prospective study of bloodstream infection in HIV-positive patients during a 15-year period
|
| García Rodríguez J., Álvarez H., Buño B., Mariño A., Rodríguez M., Sesma P. |
| |
|
A prospective study of tigecycline susceptibility of bacteria isolated from complicated intra-abdominal as well as skin and soft tissue infections in a large UK hospital
|
| Oliver L., Watson E., Hovenden J., Budai I., Marodi C. |
| |
|
A proteomics approach to understanding the pathogenesis mechanisms of the obligate intracellular pathogen Coxiella burnetii
|
| Samoilis G., Psaroulaki A., Vougas K., Gikas A., Tselentis Y., Tsiotis G. |
| |
|
A pseudo-outbreak of a Citrobacter with an extended-spectrum b-lactamase in a haemato-oncology ward
|
| Jansen L., Bakkers J., Wulf M. |
| |
|
A pseudo-outbreak with Mycobacterium intracellulare
|
| Van De Vyvere M., Vanpellicom J., Verschueren M., Camps K., Winnepenninckx L., Bomans P. |
| |
|
A quantitative analysis of clincal nasal swab samples testing positive for methicillin-resistant Staphylococcus aureus
|
| Mermel L., Lonks J., Gordon S., Perl T., Fadem S., Acharya M., Dacus D., Eells S., Maxey G., Cartony J., Morse D.J., Wood M.E., Mach P.A., Jacobson C.J. |
| |
|
A randomised trial of 2% chlorhexidine in 70% alcohol compared with 10% povidone-iodine for venipuncture site disinfection: effects on blood culture contamination rates
|
| Suwanpimolkul G., Pongkumpai M., Kulwichit W., Suankratay C. |
| |
|
A real-time PCR assay for detection of six common species of Candida from blood, validated in adult critically ill patients
|
| McMullan R., Metwally L., Coyle P., Hedderwick S., McCloskey B., O'Neill H., Webb H., Hay R. |
| |
|
A real-time PCR assay for typing emerging pneumococcal serotypes
|
| Tarrago D., Fenoll A., Obando I., Sanchez-Tatay D., Arroyo L., Casal J. |
| |
|
A real-time PCR protocol to detect Neisseria meningitidis in formalin-fixed paraffin-embedded tissues
|
| Fernandez-Rodriguez A., Alcala B., Vallejo G., Gómez J., Alvarez-Lafuente R. |
| |
|
A retrospective study of 230 consecutive patients hospitalised after transcontinental travel
|
| Leroy H., Arvieux C., Biziragusenyuka J., Chapplain J., Guiguen C., Michelet C., Tattevin P. |
| |
|
A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and candidaemia
|
| Ullmann A.J., De Waele J., Betts R., Rotstein C., Nucci M., Cornely O.A. |
| |
|
A risk of tuberculosis persists in patients treated with anti TNF-a antagonist therapy despite prophylactic guidelines: identification of main risk factors
|
| Mariette X., Lortholary on behalf of RATIO O., Salmon D., Tubach F., Ravaud P., Chiche Manian R., Michelet C., Dellamonica P., Benammar N. |
| |
|
A risk score for unfavourable outcome in adults with bacterial meningitis
|
| Weisfelt M., van de Beek D., Spanjaard L., Reitsma J.B., de Gans J. |
| |
|
A semi-automated procedure for monitoring of cytomegalovirus
|
| Törmänen V., Prieto J., Finnström N., Jansson B. |
| |
|
A serological survey of measles among a group of adults receiving measles, rubella booster mass vaccination in Iran, 2003. A preliminary report
|
| Emami Naeini A., Rostami M. |
| |
|
A single-tube real-time PCR and melting-curve analysis for detection and characterisation of TEM-type extended-spectrum b-lactamases
|
| Nikulin A., Alexeev Y., Edelstein M. |
| |
|
A six-year surveillance of the epidemiology and aetiology of the bacteriaemias at a Milan hospital. The clinical relevance of haemoculture
|
| Cainarca M., Tarricone C., Ranieri R., Erba C., D'Arminio Monforte A., Melzi d'Eril G. |
| |
|
A study on Candida blood stream infection at university hospitals, Leicester, UK
|
| Hardman S.C., Perera N. |
| |
|
A surgeons perspective on staphylococcal infection
|
| Morgan-Jones R., Kluytmans J., Bonten M. |
| |
|
A survey of multi-drug resistance clinical pathogens in Turkey – T.E.S.T. Program, 2006
|
| Bouchillon S., Badal R., Hackel M., Johnson J., Hoban D., Johnson B., Dowzicky M. |
| |
|
A teicoplanin-resistant mutant of methicillin-resistant Staphylococcus aureus exhibits increased uptake and improved survival in non-professional phagocytes
|
| Renzoni A., Huggler E., Lew D., Kelley W., Vaudaux P. |
| |
|
A two-year study of antibiotic resistance in Enterococci isolated from food, abattoirs and farms in Scotland and its link to hospital-acquired infections
|
| Vali L., Hamouda A., Mateus A., Walker D.J., Dave J., Gibb A., Amyes S.G.B. |
| |
|
Ability of Iranian microbiology laboratories for detection and susceptibility testing of unknown micro-organisms: survey results of 2149 laboratories
|
| Rahbar M., Saremi M., Sabourian R., Hekmat yazdi S. |
| |
|
Accuracy of b-lactam susceptibility testing results from VITEK and VITEK 2 systems when testing Pseudomonas aeruginosa
|
| LaBombardi V., Rekasius V., Schreckenberger P., Jones R. |
| |
|
Accuracy of the VITEK 2 system to identify coagulase-negative staphylococci
|
| Sáez A., Ruiz del Castillo B., Agüero J., Martínez-Martínez L. |
| |
|
Activity of cefditoren versus seven other antimicrobials against amoxicillin non-susceptible Streptococcus pneumoniae
|
| Perez-Trallero E., Marimon J., Erzibengoa M., Gimenez M., Coronel P., Aguilar L. |
| |
|
Activity of ceftobiprole against Pseudomonas aeruginosa clinical isolates from Europe collected in 2005–2006
|
| Davies T., Sahm D., Flamm R., Bush K. |
| |
|
Activity of ceftobiprole against US clinical S. pneumoniae isolates that are ceftriaxone non-susceptible
|
| Davies T., Bush K., Appelbaum P. |
| |
|
Activity of ceftobiprole tested against contemporary European Enterobacteriaceae and Pseudomonas aeruginosa (2005–2006)
|
| Fritsche T., Sader H., Strabala P., Jones R. |
| |
|
Activity of ceftobiprole tested against staphylococcal and streptococcal isolates recovered from patients in European medical centres (2005–2006)
|
| Fritsche T., Sader H., Strabala P., Jones R. |
| |
|
Activity of daptomycin against coryneform bacteria isolated from clinical samples
|
| Salas C., Calvo J., Martínez-Martínez L. |
| |
|
Activity of daptomycin and selected antimicrobial agents tested against Gram-positive organisms isolated from European patients with complicated skin and skin structure infections
|
| Sader H., Fritsche T., Strabala P., Jones R. |
| |
|
Activity of daptomycin on biofilms produced on plastic support by Staphylococcus species
|
| Roveta S., Marchese A., Schito G. |
| |
|
Activity of human b-defensin 3 against metallo-b-lactamase-producing Pseudomonas aeruginosa strains
|
| Kazakos E., Bisiklis A., Alexiou-Daniel S., Bajaj-Elliott M. |
| |
|
Activity of linezolid against a worldwide collection of uncommonly isolated Gram-positive organisms (3,251 strains)
|
| Jones R., Ross J., Stilwell M. |
| |
|
Activity of moxifloxacin and cefuroxime against MSSA in time-kill and in vitro PK/PD studies
|
| Endermann R., Weskott G., Pickbrenner A., Schuhmacher J., Kne[zcaron]evic I. |
| |
|
Activity of posaconazole against clinical isolates of Candida albicans with decreased sensitivity to fluconazole from autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy patients
|
| Rautemaa-Richardson R., Richardson M., Pfaller M., Koukila-Kähkölä P., Perheentupa J., Saxen H. |
| |
|
Activity of telavancin against Staphylococcus aureus isolates carrying the Panton-Valentine leukocidin gene in the ATLAS studies
|
| Fowler Jr V.G., Rude T., Nelson C., Stryjewski M.E., Kitt M.M., Barriere S.L., Friedland D., Corey G.R. |
| |
|
Activity of tigecycline against ESBL-producing enterobacteria spreading in Italy
|
| Luzzaro F., Mugnaioli C., Gualandris S., Pallecchi L., Brigante G., Pini B., Rossolini G.M., Toniolo A. |
| |
|
Activity of tigecycline versus carbapenem-resistant strains of Acinetobacter spp.
|
| Khanna P., Krahe D., Bean D., Wareham D. |
| |
|
Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient
|
| Amini-Bavil-Olyaee S., Heim A., Luedde T., Manns M., Trautwein C., Tacke F. |
| |
|
Adequacy and efficacy of initial empiric antibiotic treatments in severe nosocomial infections in ICU departments: results of multicentre randomised study
|
| Yakovlev S., Beloborodov V., Sidorenko S., Ovechkin A., Yakovlev V. |
| |
|
Adherence to surgical site infection guidelines in Italian heart surgery units
|
| Pan A., Ambrosini L., Lorenzotti S., Soavi L., Signorini on behalf of the GIS-INFCARD investigators L. |
| |
|
Adhesion of Staphylococcus epidermidis to a modified cellulose triacetate membrane
|
| Extremina C.I., Granja P.L., Freitas da Fonseca A., Fonseca A.P. |
| |
|
Administration of DNA vaccine containing E6 gene of HPV16 in order to evaluate cellular immunity
|
| Soleimanjahi H., Hassan Z., Poorpak Z., Meshkat Z., Mirshahabi H., Meshkat M. |
| |
|
Administration of TNF-a did not inhibit Mycobacterium avium infection in the mouse lung
|
| Fujita M., Ikegame S., Harada E., Ouchi H., Inoshima I., Nakanishi Y. |
| |
|
Adverse events and b-lactam trough plasma concentrations during the treatment of endocarditis
|
| Tattevin P., Tribut O., Polard E., Gouaillier F., Mercier M., Kervegant C., Chapplain J., Arvieux C., Michelet C. |
| |
|
Adverse reactions to imipenem therapy in adult patients with sepsis
|
| Ciubotariu D., Ghiciuc C., Luca V., Nechifor M. |
| |
|
Aetiology of withdrawal lopinavir/ritonavir in a group of HIV-infected patients and evolution of subjects changed to other treatments in a simplification strategy
|
| Moreno V., Valencia E., Jiménez-Nácher I., González Lahoz J. |
| |
|
Affect of length of hospitalisation on susceptibility patterns of Gram-negative bacilli isolated from intra-abdominal infections: SMART 2005
|
| Gallagher G., Rossi F., Hsueh P.R., Báez-Villaseñor J., Wilson H.M., Abramson M. |
| |
|
Alert pathogens in blood of haematological patients from 2004 through 2005
|
| Marchel H., Wróblewska M., Kamola R., Majewska A., Luczak M. |
| |
|
Alterations of serum lipoproteins in patients with acute brucellosis
|
| Apostolou F., Kostoula A., Liberopoulos E., Gazi I., Spyrou A., Tsianos E., Bairaktari E., Tselepis A., Elisaf M. |
| |
|
Altered outer membrane protein profiles of Pseudomonas aeruginosa highly susceptible to the efflux pump inhibitor Phe-Arg-b-naphthylamide
|
| Campo-Esquisabel A.B., Martí S., Sierra J.M., Martinez-Martinez L., Vila J. |
| |
|
Alveolar macrophage phagocytosis and respiratory burst activity is regulated by Lyn–PI3Kinase–Akt pathway
|
| Kannan S., Audet A., Huang H., Wu M. |
| |
|
Ambulatory care self-medication with antibiotics within countries in the south-eastern Mediterranean region: results from the ARMed project
|
| Scicluna E.A., Borg M.A., Collaborators ARMed Project |
| |
|
Aminoglycoside-induced apoptosis in cultured renal (LLC-PK1) and non-renal (J774 macrophages) cells: comparison between gentamicin and amikacin
|
| Denamur S., Van Bambeke F., Mingeot-Leclercq M.-P., Tulkens P. |
| |
|
Aminoglycosides, mortality and increase of serum-creatinine in patients with bacteraemia given appropriate empirical therapy. A Danish hospital-based cohort study
|
| Schønheyder H., Freundlich M., Pedersen L., West H., Thomsen R. |
| |
|
Amoebae as a second host for Vibrio cholerae
|
| Sandström G., Saeed A., Edvinsson B., Weintraub A., Abd H. |
| |
|
Amphotericin B does not affect the pharmacokinetics of micafungin (FK463)
|
| Undre N., Stevenson P., Wilbraham D. |
| |
|
Amplification and sequencing of a 190bp segment containing nucleotide 6240 from prototype human papillomavirus16 L1 gene and 10 clinical isolates from the UK
|
| Al Zoubi H., Vallely P., Turner A., Guiver M. |
| |
|
An analysis of the efficacy of micafungin in Candida infections caused by non-albicansCandida species in phase III trials
|
| Cornely O.A., De Waele J., Betts R., Rotstein C., Nucci M., Kovanda L., Wu C., Ullmann A.J. |
| |
|
An epidemiological analysis of Streptococcus pneumoniae infection in outpatient acute exacerbations of chronic bronchitis
|
| Weber P., Anzueto A., Garau J., Guillemot D., Gaillat J., Sethi S. |
| |
|
An evaluation of MicroScan WalkAway results for broad-spectrum b-lactams when testing Pseudomonas aeruginosa
|
| Lerner S., Salimnia H., Steed L., Bosso J., Jones R. |
| |
|
An evaluation of the rapid transport of BacT/ALERT blood culture bottles via a vacuum sample transport system at a UK regional hospital
|
| Joslin L. |
| |
|
An investigation of a cluster of parapoxvirus cases in Missouri, February–May 2006
|
| Lederman E., Tao M., Pue H., Reynolds M., Smith S., Li Y., Zhao H., Sitler L., Mahmutovic A., Emerson G., Hutson C., Bensyl D., Regnery R., Zhu B., Damon I. |
| |
|
An IS6110-targeting fluorescent amplified fragment length polymorphism DNA fingerprinting alternative to IS6110 RFLP: a pilot study
|
| Thorne N., Evans J., Smith E.G., Hawkey P., Gharbia S., Arnold C. |
| |
|
An open-label, randomised, comparative study of the patient compliance, efficacy and safety of treatment with clarithromycin extended-release versus clarithromycin immediate-release for the treatment of acute bacterial exacerbation of chronic bronchitis
|
| Kardas P. |
| |
|
An outbreak of fungaemia in a neonatal intensive care unit in Kuwait caused by Candida haemulonii resistant to amphotericin B, itraconazole and fluconazole
|
| Khan Z., Al-Sweih N., Ahmad S., Al-Kazemi N., Khan S., Joseph L., Chandy R. |
| |
|
An outbreak of pneumonia caused by S. pneumoniae at a military training facility in Finland in 2006
|
| Vainio A., Lyytikäinen O., Skyttä R., Kaijalainen T., Virolainen A. |
| |
|
An unusual presentation of acute brucellosis with thrombocytopenia and maculopapular rash
|
| Alici O., Kasapoglu B., Alkan R., Sarifakioglu E., Akgedik R., Bozalan R., Kosar A., Sahin H. |
| |
|
Anaerobic microbiology of peritoneal cavity specimens in childhood
|
| Vlachou M., Garantziotou D., Kaleyias J., Galanopoulou L., Rouli V., Apostolaki T., Koureli O., Spiliopoulou A., Gatopoulou A. |
| |
|
Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates in the United Arab Emirates
|
| Alfaresi M., Elkouch A., Abdulsalam A. |
| |
|
Analysis of AtheNA Multi-Lyte HIV-1 Test for confirmation of HIV-1 infection
|
| Wang Y., Suantio A., Pogue Y. |
| |
|
Analysis of clinical characteristics in 53 patients with Crypotococcus neoformans meningitis
|
| Lu X.J. |
| |
|
Analysis of essential gene changes in MRSA and non-MRSA strains inhibited by methanolic extract correlated to membrane permeabilising peptide
|
| Shamsudin M., Alipiah N., Vasantha N., Yusoff F., Arshad A. |
| |
|
Analysis of IgG and IgM in patients pre-diagnosed with toxoplasmosis
|
| Sönmez Tamer G., Mutlu B., Willke A. |
| |
|
Analysis of in vitro Streptococcus pneumoniae non-susceptibility to several antimicrobial agents in a children's hospital in Turkey (1997–2005)
|
| Gur D., Guciz Dogan B. |
| |
|
Analysis of mixed microbial species in clinically relevant biofilms using denaturing HPLC
|
| Jury F., Bueid A., Ollier W., Fox A., Upton M. |
| |
|
Analysis of plasmids from multi-resistant and multi-plasmid clinical E. coli strain CZD1527
|
| Wolinowska R., Strzezek K., Zaleski P., Chodnicka J., Lakomy A., Demianczuk A., Plucienniczak A. |
| |
|
Analysis of reports of Clostridium difficile infection in phase 2 and 3 studies of tigecycline
|
| Wilcox M., Freeman J. |
| |
|
Analysis of the comparative work-flow and accuracy of the VITEK 2 Compact and the combination mini-API/Agar diffusion SIRSCAN method
|
| Doat V., Roubille M. |
| |
|
Analysis of the effect of selected antiseptics and antibiotics on the survival of planktonic celles and biofilm cells
|
| Bartoszewicz M., Rygiel A., Przondo-Mordarska A. |
| |
|
Analysis of tigecycline activity against Acinetobacter spp. and Enterobacteriaceae based on clinical specimen source
|
| Draghi D., Dowzicky M., Jones M., Brown N., Thornsberry C., Sahm D. |
| |
|
Analysis of tigecycline activity against Staphylococcus aureus based on clinical specimen source
|
| Draghi D., Dowzicky M., Brown N., Jones M., Thornsberry C., Sahm D. |
| |
|
Antagonistic activity of Lactobacillus acidophilus toward clinical strains of Helicobacter pylori
|
| Andrzejewska E., Szkaradkiewicz A. |
| |
|
Antibacterial activity of tigecycline against H. influenzae and S. pneumoniae (2004–06) Global Population – T.E.S.T. Program, 2006
|
| Bouchillon S., Hackel M., Johnson J., Badal R., Hoban D., Johnson B., Dowzicky M. |
| |
|
Antibiotic consumption in three hospitals, Latvia, 2005
|
| Berzina S., Ferech M., Saule L., Umbrasko D., Jekabsone I., Goosens for ESAC H. |
| |
|
Antibiotic diffusion in pseudoarthrosic infected bone: glycopeptides, fluoroquinolones and carbapenems
|
| Garazzino S., Aprato A., Aloj D., De Rosa F.G., D'Avolio A., Massé A., Di Perri G. |
| |
|
Antibiotic resistance among Gram-negative bacilli causing meningitis in an adult neurosurgical centre in Manchester, UK: implications for effective antibiotic therapy
|
| Doshi N., Wilson T., Subudhi C. |
| |
|
Antibiotic resistance amongst cutaneous propionibacteria from Egyptian acne patients
|
| El-Mahdy T.S.M., Abd-Elaziz M.M., El-Sayed M.H., Ross J.I., Abd-Allah S., Radwan H., Snelling A.M. |
| |
|
Antibiotic resistance conferred by a class 1 integron and SXT element in different Vibrio cholerae O-serotype isolated in Algeria
|
| Ammari H., Ruimy R., Skurnik D., Andremont A., Mazel D., Guerout A., Assaous F., Rahal K. |
| |
|
Antibiotic resistance of Helicobacter pylori strains isolated from gastric biopsy specimens in Iran
|
| Mohabbati Mobares A., Haghi Tomatari F., Amini M., Hosseini Doust R. |
| |
|
Antibiotic resistance of Stenotrophomonas maltophilia in children with cystic fibrosis to the currently used antibiotics
|
| Alexandrou-Athanasoulis H., Doudounakis S., Samantas K., Papavasiliou J., Baclakou C., Pangalis A. |
| |
|
Antibiotic resistance of community-acquired urinary tract infections in south-east Austria. Emergence of E. coli producing extended-spectrum b-lactamase
|
| Badura A., Feierl G., Grisold A., Masoud L., Wagner-Eibel U., Marth E. |
| |
|
Antibiotic resistance of enterococci isolated from blood cultures during 2003–2006
|
| Arslan U., Feyzioglu B., Uysal E.B., Tuncer E.I., Findik D. |
| |
|
Antibiotic susceptibility of Yersinia strains in Kazakhstan
|
| Nekrassova L., Meka-Mechenko T., Aikimbayev A., Temiralieyva G. |
| |
|
Antibiotic usage and resistance development in an intensive care unit
|
| Lapatschek M.S., Hartinger A. |
| |
|
Antibiotic usage and resistance patterns in a Saudi tertiary hospital
|
| Al-Jamal M., Al-Barrak A., Elkhizzi N. |
| |
|
Antibiotic use in German intensive care units
|
| Meyer E., Schwab F., Gastmeier P., Rueden H., Jonas D. |
| |
|
Antibodies against LTA isolated from E. faecalis 12030 recognize LTA from heterologous enterococcal strains but mediate opsonophagocytic killing only to CPS-A and CPS-B strains
|
| Toma I., Theilacker C., Sava I., Kropec A., Hammer F., Huebner J. |
| |
|
Antibody decay profiles during Yersinia enterocolitica O:3 infections: a follow-up study of 94 patients
|
| Rasmussen E., Schiellerup P., Dalby T., Krogfelt K. |
| |
|
Antibody response in Crimean-Congo haemorrhagic fever, and association between antibodies and clinical outcome
|
| Özkurt Z., Özden K., Kadanali A., Erol S., Yilmaz N., Parlak M. |
| |
|
Antifungal activity of human monocytes alone and combined with caspofungin against Candida albicans biofilm and planktonic cells
|
| Katragkou A., Simitsopoulou M., Dalakiouridou M., Diza-Mataftsi E., Tsantali C., Roilides E. |
| |
|
Antifungal activity of miconazole against recent clinical isolates of Candida spp., as determined by minimum inhibitory concentration
|
| Ghannoum M.A. |
| |
|
Antifungal chemoprophylaxis in the very low birth weight neonates: a prospective randomised controlled study
|
| Klimko N., Kolbin A., Shabalov N. |
| |
|
Antifungal drug susceptibility testing of Candida sp. by two methods: CLSI(M27-A2) broth microdilution and the image analyser method Wider-I
|
| Rodriguez-Dominguez M., Ayala G., Fernandez-Olmos A., Mercadillo M., Alvarez M., Sanchez-Sousa A., Espinel-Ingroff A. |
| |
|
Antifungal prophylaxis for patients undergoing chemotherapy or haematopoeitic stem cell transplantation – meta-analysis
|
| Robenshtok E., Gafter-Gvili A., Paul M., Goldberg E., Vidal L., Leibovici L. |
| |
|
Antifungal susceptibility of Candida clinical isolates in Canada: a ten-year review
|
| Fuller J., Sand C., Rennie R. |
| |
|
Antifungal susceptibility patterns of Candida isolates recovered from bloodstream infections: a 3-year study
|
| Kopsari K., Zarkotou O., Avramioti V., Chrysos G., Gianneli D. |
| |
|
Antifungal susceptibility testing
|
| Rodriguez Tudela J.L. |
| |
|
Antifungal utilisation in a haematology unit in Turkey: a part of the FUNGOBASE Study
|
| Azap A., Kumbasar Ö., Akan H. |
| |
|
Anti-giardial activity of phenolic essential oils
|
| Cavaleiro C., Gaspar B., Salgueiro L., Poiares-da-Silva J., Sousa M.C. |
| |
|
Antimicrobial activity of apidaecin peptides
|
| Czihal P., Nimptsch A., Möllmann U., Zipfel P., Hoffmann R. |
| |
|
Antimicrobial activity of ozonised water and 0.9% NaCl
|
| Bocian E., Bialoszewski D., Bukowska B., Czajkowska M., Tyski S. |
| |
|
Antimicrobial activity of polymyxin B against non-fermentative Gram-negative bacteria in Georgia
|
| Nanuashvili A., Kereselidze M., Davitashvili T. |
| |
|
Antimicrobial activity of tigecycline and daptomycin against Gram-positive cocci: a multicentre study in Greek hospitals
|
| Kolonitsiou F., Pratti A., Spiliopoulou I., Karanika M., Alexiou-Daniel S., Bakola D., Vergi M., Oeconomou M., Koutsia-Karouzou C., Malamou-Lada H., Zerva L., Petinaki E. |
| |
|
Antimicrobial activity of tigecycline and other broad-spectrum agents tested against bacterial isolates collected in European hospitals in 2006
|
| Sader H., Fritsche T., Stilwell M., Jones R. |
| |
|
Antimicrobial and antioxidant actions of the clubmoss Lycopodium clavatum L.
|
| Özçelik B., Orhan I., Aslan S., Kartal M., Karaoglu T., Sener B., Choudhary M. |
| |
|
Antimicrobial biodegradable composition based on high-molecular weight polyvinylpyrrolidone for the prophylaxis of experimental osteomyelitis
|
| Afinogenov G., Tikhilov R., Mironenko A., Bogdanova T., Afinogenova A., Kozlov I., Krasnova M., Anisimova L. |
| |
|
Antimicrobial consumption and resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals
|
| Rogues A., Dumartin C., Boulestreau H., Venier A., Gachie J., Marty N., Parneix P. |
| |
|
Antimicrobial consumption in Southern and Eastern Mediterranean hospitals: final results from the ARMed Project
|
| Zarb P., Borg M.A., Ferech M., Goossens H. |
| |
|
Antimicrobial effect of antibacterial essential oils and three common antiseptic products
|
| Karbach J., Königkamp S., Warnke P., Behrens E., Al-Nawas B. |
| |
|
Antimicrobial effects of non-antibiotics on resistant Gram-positive bacteria
|
| Hendricks O., Butterworth T., Christensen J., Sahly H., Podschun R., Kristiansen J. |
| |
|
Antimicrobial resistance and prevailing resistance mechanisms among problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria
|
| Strateva T., Ouzounova-Raykova V., Markova B., Marteva-Proevska Y., Mitov I. |
| |
|
Antimicrobial resistance comparisons amongst extended-spectrum b-lactamase producing Klebsiella spp. phenotypes collected from Brazilian hospitals in 2003 and 2006
|
| Mendes C., Koga P., Sakagami E., Turner P., Kiffer on behalf of the MYSTIC Group Brazil C. |
| |
|
Antimicrobial resistance in Escherichia coli from pigs in relation to incidence of post-weaning diarrhoea and antimicrobial use
|
| Andersson U.G., Bengtsson B., Franklin A., Thyselius S. |
| |
|
Antimicrobial resistance in Staphylococcus intermedius from dogs in Norway
|
| Norström M., Tharaldsen H., Solheim H., Mørk T., Bergsjø B., Sunde M. |
| |
|
Antimicrobial resistance in strains isolated in 2005 by Romanian National Sentinel System for Nosocomial Infections Surveillance
|
| Codita I., Oprea M., Petrescu A.M., Tatu-Chitoiu D., Ungureanu V., Ghita M., Lemeni D., Oancea R., Brehar-Cioflec D., Romaniuc A. |
| |
|
Antimicrobial resistance of Escherichia coli urinary isolates from primary care patients in Greece
|
| Falagas M.E., Polemis M., Alexiou V.G., Sarantou I., Kremastinou J., Vatopoulos A.C. |
| |
|
Antimicrobial resistance of Mycoplasma hominis and Ureaplasma urealyticum among women with vaginal discharge
|
| Kurti A., Mulliqi-Osmani G., Raka L., Berisha L., Jaka A., Jakupi X., Begolli L. |
| |
|
Antimicrobial resistance of Neisseria gonorrhoeae in the Russian Federation in 2006
|
| Kubanova A.A., Frigo N.V., Priputnevich T.V., Sidorenko S.V. |
| |
|
Antimicrobial resistance of S. aureus strains isolated in 2005 from nosocomial infections in Romania
|
| Dragomirescu C.C., Codita I., Oprea M. |
| |
|
Antimicrobial resistance of S. pyogenes in Russia: results of prospective multicentre study PEHASus
|
| Kozlov R., Sivaja O. |
| |
|
Antimicrobial resistance of Staphylococcus aureus nosocomial blood isolates in Russian intensive care units
|
| Dekhnich A., Ryabkova E., Kretchikova O., Ivanchik N. |
| |
|
Antimicrobial resistance of Streptococcus pneumoniae strains to penicillin and ceftriaxone, isolated in the Ni[scaron] district, Romania during 1999–2006
|
| Mladenovic-Antic S., Kocic B., Stojanovic P., Ivic S., Mladenovic V. |
| |
|
Antimicrobial resistance of clinical isolates Acinetobacter baumannii in a university hospital
|
| Stoeva T., Savov E., Bojkova K. |
| |
|
Antimicrobial resistance patterns and genotypes of Streptococcus agalactiae and Streptococcus dysgalactiae ssp. dysgalactiae from bovine mastitis in Portuguese dairy farms
|
| Rato M., Rolo D., Bexiga R., Nunes S.F., Cavaco L.M., Vilela C.L., Santos-Sanches I. |
| |
|
Antimicrobial resistance patterns of Acinetobacter baumannii and Pseudomonas aeruginosa isolates in a hospital in Algiers, Algeria
|
| Ramdani-Bouguessa N., Djennane F., Neggazi M., Tazir M. |
| |
|
Antimicrobial resistance profiles of Acinetobacter baumannii strains isolated in intensive care units
|
| Naim M., Chabani M., Tiouit D. |
| |
|
Antimicrobial resistance within Streptococcus pneumoniae isolates from eastern and southern Mediterranean countries
|
| Borg M.A., Scicluna E.A., Tiemersma E.W., de Kraker M., van de Sande-Bruinsma N., Monen J., Grundmann H., Collaborators ARMed Project |
| |
|
Antimicrobial susceptibilities and prevalence of qnrA in UTI isolates from hospital and the community
|
| Higgins P.G., Lohr M., Wisplinghoff F., Seifert H., Wisplinghoff H. |
| |
|
Antimicrobial susceptibility among clinical isolates of Haemophilus influenzae in a tertiary hospital in Greece
|
| Kofteridis D., Notas G., Maraki S., Samonis G. |
| |
|
Antimicrobial susceptibility and AP-PCR typing of Acinetobacter spp. strains isolated from three teaching hospitals, Tehran, Iran
|
| Sadeghifard N., Zaeimi Yazdi J., Ranjbar R., Ahmadi A., Ghasemi A., Rostamzad A. |
| |
|
Antimicrobial susceptibility and phage types of Salmonella typhimurium human strains isolated during 2002–2005 in the Slovak Republic
|
| Majtánová L., Majtán V. |
| |
|
Antimicrobial susceptibility of Nocardia spp. – experience in England and Wales
|
| Hill R.L.R., Pike R., Warner M. |
| |
|
Antimicrobial susceptibility of Peptostreptococcus anaerobius and Peptostreptococcus stomatis
|
| Könönen E., Niemi P., Kanervo-Nordström A. |
| |
|
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from lower respiratory tract infections – Therapeutic consequences
|
| Popescu C., Popescu G.A., Benea E., Popoiu M., Ivan M., Gavriliu L., Paise A. |
| |
|
Antimicrobial susceptibility of 2,254 isolates from different body sites: Tigecycline Evaluation Surveillance Trial (TEST) in South America, 2004–2006
|
| Badal R., Bouchillon S., Johnson B., Hackel M., Johnson J., Hoban D., Dowzicky M. |
| |
|
Antimicrobial susceptibility of 2,537 bacteraemia causative pathogens: Tigecycline Evaluation Surveillance Trial (TEST) in Europe, 2004–2006
|
| Badal R., Bouchillon S., Johnson B., Hackel M., Johnson J., Hoban D., Dowzicky M. |
| |
|
Antimicrobial susceptibility of anaerobic and facultative aerobic bacteria isolated from pus specimens of orofacial infections and b-lactamase production
|
| Blandino G., Milazzo I., Fazio D., Puglisi S., Speciale A. |
| |
|
Antimicrobial susceptibility of bacteria causing early onset sepsis
|
| Zisovska E., Lazarevska L., Zivkovik J. |
| |
|
Antimicrobial susceptibility of gonococci isolated in Greece in 2005. Dramatic increase in quinolone resistance rate due to a single serovar
|
| Stathi M., Avgerinou H., Miriagou V., Flemetakis A., Daniilidou M., Kyriakis K., Tzelepi E. |
| |
|
Antimicrobial susceptibility of the pathogens of bacteraemia in a tertiary neonatal intensive care unit in Bogota, Colombia, 2001–2006
|
| Contreras G., Prieto R., Leal A. |
| |
|
Antimicrobial susceptibility patterns of inducible Enterobacteriaceae isolated from intraabdominal infections in Europe: results from SMART 2005
|
| Gallagher G., Baquero F., Rossi F., Báez-Villaseñor J., Wilson H.M., Abramson M. |
| |
|
Antimicrobial susceptibility testing for Mycobacterium kansasii in Taiwan
|
| Wu T.S., Lee M.H., Leu H.S., Wu T.L., Chiang P.C., Chiu C.H. |
| |
|
Antimicrobial susceptibility to third and fourth generation cephalosporins and the prevalence of extended-spectrum b-lactamase-producing isolates among Enterobacteriaceae from different clinical specimens
|
| Kocic B., Mladenovic-Antic S., Randjelovic G., Stojanovic P., Dinic M. |
| |
|
Anti-neutrophil cytoplasmic antibodies in severe infection – a neglected association
|
| Morath C., Sis J., Zeier M., Schwenger V., Andrassy K. |
| |
|
Antiretroviral drug resistance among drug-naive HIV-infected patients in Korea
|
| Lee S-H., Rheu E-K., Cah D-H., Lee S-J., Rheu H-S., Kim H-H., Cho G-J. |
| |
|
Antiretrovirals adverse reactions from a prospective HIV/AIDS cohort study in Bogotá, Colombia
|
| Vesga J.F., Alvarez C., Tamara J.R., Cortes J.A., Guerrero P., Gil F. |
| |
|
Application of hybridisation probe-based real-time PCR assay to monitor the Brucella DNA load in patients with brucellosis throughout different stages of the disease
|
| Vrioni G., Priavali E., Pappas G., Gartzonika C., Levidiotou S. |
| |
|
Appropriateness of antibiotic therapy on weekends vs weekdays
|
| Bishara J., Hershkovitz D., Pitlik S. |
| |
|
Are our mobile phones clean?
|
| Ulger F., Esen S., Dilek A., Yanik K., Gunaydin M., Leblebicioglu H. |
| |
|
Are procalcitonin and C-reactive protein accurate prognostic markers in sepsis?
|
| Tsiavos V., Charitos D., Komitopoulou A., Kanavou A., Varsamis E., Komitopoulos N., Giakoymaki E. |
| |
|
Are recommendations for antibiotic use related to antibiotic consumption in hospital? Results from a French surveillance network
|
| Miliani K., L'Heriteau F., Arnaud I., Carbonne A., Astagneau P. |
| |
|
Are susceptibility testing results for clindamycin from microdilution automated systems reliable for therapeutic decisions?
|
| Treviño M., Moldes L., Garcia-Riestra C., Gómez-Rial M., Jorge M., Regueiro B. |
| |
|
Array-based typing of community- and healthcare associated MRSA and occurrence of epidemic strains in eastern Saxony
|
| Monecke S., Jatzwauk L., Weber S., Ehricht R. |
| |
|
Arthritis and chronic hepatitis C virus infection
|
| Puerto J., Escobar M.A., Garcia-Egido A.A., Fernandez F.J., Gomez-Soto F.M., Bernal J.A., Romero S.P., Gomez F. |
| |
|
Aspartate aminotransferase to platelet ratio index for the evaluation of fibrosis in chronic viral hepatitis
|
| Yetkin M.A., Bulut C., Çaydere M., Erdinc F.S., Ertem G., Kinikli S., Tülek N., Üstün H., Demiroz A.P. |
| |
|
Assessing Staphylococcus aureus nasal colonisation in a cohort of healthy volunteers
|
| Wood M.E., Morse D.J., Nordby T.M., Olson L.K., Mach P.A., Jacobson C.J. |
| |
|
Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination
|
| Otter J., Cummins M., Ahmad F., van Tonder C., Drabu Y. |
| |
|
Assessing the in vitro activity of daptomycin against well-characterised methicillin-resistant Staphylococcus aureus strains representing different spa types
|
| Becker K., Grünastel B., Mellmann A., Peters G., von Eiff C. |
| |
|
Assessment and management of tuberculosis infection in patients due to start anti-TNF-a treatment
|
| Casas S., Gasch O., Lora-Tamayo J., Reina D., Joanola X., Gonzalez L., Guerra M., Santin M. |
| |
|
Assessment of cefoxitin MICs with the BD Phoenix® system to detect methicillin-resistant Staphylococcus aureus isolates
|
| Morosini M.I., García-Castillo M., Loza E., Baquero F., Cantón R. |
| |
|
Assessment of electrocardiograms and garenoxacin plasma concentrations from subjects with acute bacterial infections
|
| Krishna G., Waskin H. |
| |
|
Assessment of liver cirrhosis by elastography in HCV/HIV co-infected patients
|
| Castellares C., Martín-Carbonero L., Barreiro P., Ramos B., Sheldon J., Labarga P., Novoa-Rodríguez S., González-Lahoz J., Soriano V. |
| |
|
Assessment of risk factors in continuous ambulatory peritoneal dialysis-related peritonitis attacks
|
| Yilmaz G.R., Ozturk R., Bulut C., Parpucu H., Irmak H., Kinikli S., Duranay M., Demiroz A.P. |
| |
|
Assessment of susceptibilities of a range of antibiotic-resistant clinical isolates to Aloe vera inner gel
|
| Habeeb F.M., Dashti A.A., Morrison D., Gray A.I., Ferro V.A. |
| |
|
Assessment of the Immulite systems CMV IgM assays in comparison to the Vidas assay in a clinical evaluation
|
| Vlaspolder F., Singer P. |
| |
|
Assessment of the polymyxin B antimicrobial activity tested against 26,921 clinical strains of Gram-negative bacilli collected in Europe: report from 10 years of the SENTRY Antimicrobial Surveillance Program
|
| Sader H., Fritsche T., Janechek M., Jones R. |
| |
|
Assessment of the risk factors for mortality in hospital-acquired Acinetobacter baumannii infections in a teaching hospital
|
| Bulut C., Yetkin M.A., Erdinc F.S., Ataman Hatipoglu C., Onde U., Karakoc E.A., Tülek N. |
| |
|
Assessment of tryptophan metabolism and cytokine profile in cerebrospinal fluid samples from patients with bacterial meningitis
|
| Coutinho L.G., Bellac C.L., Grandgirard D., Wittwer M., Coimbra R.S., Christen S., Agnez-Lima L.F., Marinho L.A., Leib S.L. |
| |
|
Associated factors and viral DNA in isolated hepatitis B core antibody group among healthcare workers
|
| Chiarakul S., Vuttiopas S., Eunumjitkul K., Kaewkungwal J., Poovorawan Y. |
| |
|
Association between antibiotic use and incidence of methicillin-resistant Staphylococcus aureus in general intensive care unit
|
| Pujate E., Balode A., Oss P., Dumpis U. |
| |
|
Association between opaque variants and serotypes in invasive isolates of Streptococcus pneumoniae
|
| Serrano I., Melo-Cristino J., Ramirez M. |
| |
|
Association between oral candidiasis and immunity level in a population of drug addicts in a centre for prevention and treatment of drug addictions in Rome, Italy
|
| Rocchi L., D'Alessandro D., Fabiani M., Osborn J.F., Leonardi C., Tarsitani G., Grillot R., Vescia N. |
| |
|
Association between systemic inflammation and Pneumocystis jirovecii colonisation in patients with chronic obstructive pulmonary disease
|
| Morilla R., Rivero L., Muñoz-Lobato F., Montes-Cano M., Friaza V., Respaldiza N., Medrano F., Varela J., Calderón E., de la Horra C. |
| |
|
Association of apolipoprotein E polymorphism with tuberculosis
|
| Farivar T.N., Johari P. |
| |
|
Association of FCgamma RIIA polymorphism with brucellosis
|
| Rafiei A., Ghasemian R., Hosseini khah Z., Ajami A. |
| |
|
Association of proinflammatory cytokines with fibrinolytic enzymes and biochemical parameters in childhood infectious parapneumonic effusions
|
| Chiu C.Y., Huang J.L., Wong K.S., Tsai M.H., Lin T.Y. |
| |
|
ATLAS 1: the first Phase 3 study evaluating the new lipoglycopeptide, telavancin, for the treatment of patients with complicated skin and skin structure infections
|
| Corey G.R., Stryjewski M.E., O'Riordan W.D., Fowler Jr V.G., Ross D.P., Hopkins A., Kitt M.M., Barriere for the ATLAS Study Group S.L. |
| |
|
ATLAS 2: a double-blind, randomised, active controlled, multinational Phase 3 study comparing telavancin with vancomycin for the treatment of patients with complicated skin and skin structure infections
|
| Corey G.R., Stryjewski M.E., Fowler Jr V.G., Teglia O., Hopkins A., Kitt M.M., Barriere for the ATLAS Study Group S.L. |
| |
|
Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: a comparative European study
|
| Grigoryan L., Birkin J., Burgerhof J., Degener J., Deschepper R., Stålsby Lundborg C., Monnet D., Scicluna E., Haaijer-Ruskamp F., Di Matteo A., Tambi-Andrasevic A., Andrajati R., Edelstein H., Valinteliene R., Mechtler R., Deliens L., Van der Kelen on behalf of the SAR consortium G. |
| |
